Impact of prenatal screening on the birth status of fetuses with Down syndrome at an urban hospital, 1972-1994

Genetics in Medicine

Volumn 1, Issue 1, 1998, Pages 22-28

  Caruso, Tamsen M ^b   Westgate, Marie Noel ^b   Holmes, Lewis B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Down syndrome; Prenatal diagnosis

Indexed keywords

ABORTION; ADULT; ARTICLE; DEMOGRAPHY; DOWN SYNDROME; FEMALE; FETUS; HOSPITAL; HUMAN; MATERNAL AGE; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PREVALENCE; QUESTIONNAIRE; UNITED STATES;

ABORTION, EUGENIC; ADULT; BOSTON; DEMOGRAPHY; DOWN SYNDROME; FEMALE; FETUS; HOSPITALS, URBAN; HUMANS; INFANT, NEWBORN; MATERNAL AGE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PREVALENCE; QUESTIONNAIRES;

EID: 0032195410     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/00125817-199811000-00006     Document Type: Review

References (29)

1. Ferguson-Smith MA, Yates JRM. Maternal age-specific rates for chromosomal aberrations and factors influencing them: Report of a collaborative study on 52,965 amniocenteses. Prenat Diagn 1984;4:5-44.
2. Hook EB, Cross PK, Regal RR. The frequency of 47,21,47, +18, and 47, +13 at the upper-most extremes of maternal ages: Results on 56,094 fetuses studied prenatally and comparison with data on livebirths. Hum Genet 1984;68:211-220.
3. DiMaio MS, Baumgarten A, Greenstein RM, Saal HM, Mahoney MI. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. N Engl J Med 1987;317:342-346.
4. Benacerraf BR, Gelman R, Frigoletto FD. Sonographic identification of second-trimester fetuses with Down's syndrome. N Engl J Med 1987;317:1371-1376.
5. Hook EB, Topol BB, Cross PK. The natural history of cytogenetically abnormal fetuses detected at midtrimester amniocentesis which are not terminated electively: New data and estimates of the excess and relative risk of late fetal death associated with 47, +21 and some other abnormal karyotype. Am J Hum Genet 1989;45:855-861.
6. Snijders RJ, Holzgreve W, Cuckle H, Nicolaides KH. Maternal age-specific risks for trisomies at 9-14 weeks' gestation. Prenat Diag 1994;14:543-552.
7. Nelson K, Holmes LB. Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med 1989;320:19-23.
8. Lieberman E, Ryan KJ, Monson RR, Schoenbaum SC. Medical and socioeconomic characteristics accounting for racial differences in the rates of premature births. N Engl J Med 1987;33:3-7.
9. Department of Obstetrics and Gynecology. Annual reports, 1983 to 1994, from the Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA.
10. Benacerraf BR, Greene MF, Saltzman DH, Barss VA, Penso CA, Nadel AS, et al. Early amniocentesis for prenatal cytogenetic evaluation. Radiology 1988;169:709-10.
11. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities. Am J Obstet Gynecol 1984;148:886-894.
12. Goodburn SF, Yates JRW, Raggatt PR, Carr C, Ferguson-Smith ME, Milton PJD, et al. Second trimester maternal screening using alpha-fetoprotein, human chorionic gonadotrophin and unconjugated oestriol: Experience of a regional program. Prenat Diag 1994;14:391-402.
13. Wu LB. Maternal serum α-fetoprotein screening and Down's syndrome. Am J Obstet Gynecol 1986;155:1362-1363.
14. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick J, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992,327:588-593.
15. Benson CB, Bieber FR, Genest DR, Doubilet PM. Doppler demonstration of reversed umbilical blood flow in an acardiac twin. J Clin Ultrasound 1989;17:291-295.
16. Vincent VA, Edwards JG, Young SR, Nachtigal M. Pregnancy termination because of chromosomal abnormalities: A study of 26,950 amniocenteses in the southeast. South Med J 1991;84:1210-1213.
17. Alberman E, Mutton D, Ide R, Nicholson A, Bobrow M. Down's syndrome births and pregnancy terminations in 1989 to 1993: Preliminary findings. Br J Obstet Gynaecol 1995;102:445-447.
18. Limb C, Holmes LB. Anencephaly: Changes in prenatal detection and birth status, 1972 through 1990. Am J Obstet Gynecol 1994;170:1333-1338.
19. Brower C, Raymond M, Lamley J, Bury G. Trends in neural tube defects 1980-1989. Med J Aust 1993;158:152-154.
20. Sharland G. Changing impact of fetal diagnosis of congenital heart disease. Arch Dis Child Fetal Neonatal Ed 1997;77:F1-F3.
21. Olsen CL, Cross PK, Gensburg LJ, Hughes JP. The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992. Prenat Diagn 1996;16:991-1002.
22. Stoll C, Alembik Y, Dott B, Roth MP. Recent trends in the prevalence of Down syndrome in north-eastern France. Ann Genet 1994;37:179-183.
23. Anderman E, Mutton D, Ide R, Nicholson A, Bobrow M. Down's syndrome births and pregnancy terminations in 1989 to 1993: Preliminary findings. Br J Obstet Gynaecol 1995;102:445-447.
24. Hook EB. Contribution of chromosome abnormalities to human morbidity and mortality. Cytogenet Cell Genet 1982;33:101-106.
25. Baird PA, Sadovnick AD. Maternal age-specific rates for Down syndrome: Changes over time. Am J Med Genet 1988;29:917-927.
26. Walker S, Howard PJ. Cytogenetic prenatal diagnosis and its relative effectiveness in the Mersey region and North Wales. Prenat Diagn 1986;6:13-23.
27. Mikkelson M. The incidence of Down's syndrome and progress towards its reduction. Philos Trans R Soc Lond B Biol Sci 1988;319:315-324.
28. Priest JH, Fernhoff PM, Elsas LJ, Huether CA. Prenatal diagnosis in metropolitan Atlanta and the impact on autosomal trisomies. Am J Obstet Gynecol 1988;159:1306-1307.
29. Palomaki GE, Haddow JE, Beauregard LJ. Prenatal screening for Down's syndrome in Maine, 1980 to 1993. N Engl J Med 1996;334:1409-1410.